Literature DB >> 15731774

Maspin expression in CIN 3, microinvasive squamous cell carcinoma, and invasive squamous cell carcinoma of the uterine cervix.

Chengen Xu1, M Ruhul Quddus, C James Sung, Margaret M Steinhoff, Cunxian Zhang, W Dwayne Lawrence.   

Abstract

Maspin is a serine protease inhibitor with tumor suppression activity. It is expressed in normal breast and prostate tissue but is downregulated or absent in breast and prostate tumors. Recent reports have shown that decreased expression is associated with a greater propensity for metastasis in oral squamous cell carcinomas. We know that some high-grade cervical intraepithelial neoplasia progress to invasive carcinomas while others either persist at the same degree of atypia or regress. The pattern of maspin expression in cervical intraepithelial neoplasia-grade 3, microinvasive squamous carcinomas and overtly invasive squamous cell carcinomas of the uterine cervix was studied to determine the relationship between the extent of maspin expression and the progression of cervical intraepithelial neoplasia to squamous cell carcinoma. In total, 36 cases were evaluated: 18 cases of cervical intraepithelial neoplasia-grade 3, seven cases of microinvasive squamous cell carcinoma and 11 cases of invasive squamous cell carcinoma. A monoclonal antibody was used on paraffin-embedded tissues. Immunoreactivity was scored semiquantitatively using a scale of 0-3. The sums of the scores of the different groups were compared using the Mann-Whitney U-test. A significant decrease in maspin scores was noted between cervical intraepithelial neoplasia-grade 3 vs invasive squamous cell carcinoma (P<0.005), microinvasive squamous cell carcinoma vs invasive squamous cell carcinoma (P<0.05), and cervical intraepithelial neoplasia-grade 3 vs tumor emboli (P<0.005). Although not statistically significant, scores of cervical intraepithelial neoplasia-grade 3 associated with invasive squamous cell carcinoma were lower compared to that cervical intraepithelial neoplasia-grade 3 without invasive squamous cell carcinoma. These findings suggest that maspin likely plays a role in disease progression from in situ to invasive carcinoma. Virtual absence of maspin immunopositivity in tumor emboli indicates that maspin may also play a role in metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731774     DOI: 10.1038/modpathol.3800393

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  6 in total

1.  Expression of maspin in the early pregnant mouse endometrium and its role during embryonic implantation.

Authors:  Yan Huang; Lu-Wei Cai; Rong Yang
Journal:  Comp Med       Date:  2012-06       Impact factor: 0.982

2.  Re-expression of Selected Epigenetically Silenced Candidate Tumor Suppressor Genes in Cervical Cancer by TET2-directed Demethylation.

Authors:  Christian Huisman; Monique G P van der Wijst; Matthijs Schokker; Pilar Blancafort; Martijn M Terpstra; Klaas Kok; Ate G J van der Zee; Ed Schuuring; G Bea A Wisman; Marianne G Rots
Journal:  Mol Ther       Date:  2015-12-21       Impact factor: 11.454

3.  TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions.

Authors:  Anna Manawapat-Klopfer; Louise T Thomsen; Peter Martus; Christian Munk; Rainer Russ; Hans Gmuender; Kirsten Frederiksen; Juliane Haedicke-Jarboui; Frank Stubenrauch; Susanne K Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2016-07-01       Impact factor: 6.166

4.  Aberrant signaling pathways in squamous cell lung carcinoma.

Authors:  Ivy Shi; Nooshin Hashemi Sadraei; Zhong-Hui Duan; Ting Shi
Journal:  Cancer Inform       Date:  2011-11-21

5.  Expression and localization of maspin in cervical cancer and its role in tumor progression and lymphangiogenesis.

Authors:  Zhiqiang Liu; Yangyang Shi; Wei Meng; Yufang Liu; Kaixuan Yang; Shuhua Wu; Zhilan Peng
Journal:  Arch Gynecol Obstet       Date:  2014-02       Impact factor: 2.344

6.  Large-scale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 E6 and E7 oncogenes.

Authors:  Mark A Merkley; Ellen Hildebrandt; Robert H Podolsky; Hilal Arnouk; Daron G Ferris; William S Dynan; Hubert Stöppler
Journal:  Proteome Sci       Date:  2009-08-23       Impact factor: 2.480

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.